SCHEMBL9928266

SCHEMBL9928266

CCNc1ncnc2[nH]cc(CC)c12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IRAK4 Q9NWZ3 3/20 0.54
TRPA1 O75762 1/20 0.45
JAK3 P52333 2/20 0.45
PRKD3 O94806 3/20 0.43
MAP4K4 O95819 3/20 0.43
PRKACA P17612 3/20 0.43
CLK2 P49760 3/20 0.43
GSK3A P49840 3/20 0.43
GSK3B P49841 3/20 0.43
CDK5 Q00535 3/20 0.43
MAP4K2 Q12851 3/20 0.43
DYRK1A Q13627 3/20 0.43
NTRK3 Q16288 3/20 0.43
CLK4 Q9HAZ1 3/20 0.43
PLK4 O00444 2/20 0.43
AURKA O14965 2/20 0.43
ROCK2 O75116 2/20 0.43
CDK1 P06493 2/20 0.43
ROS1 P08922 2/20 0.43
FGFR1 P11362 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9928265 0.87 IRAK4 (0.47) IRAK4TRPA1JAK3PRKD3MAP4K4
SCHEMBL22524312 0.84 IRAK4 (0.51) IRAK4TRPA1JAK3PRKD3MAP4K4
SCHEMBL9928270 0.79 ALOX15 (0.41) IRAK4JAK3PRKD3MAP4K4PRKACA
SCHEMBL25776394 0.77 TRPA1 (0.51) IRAK4TRPA1JAK3MAP4K1CYP1A2
SCHEMBL9928268 0.76 IRAK4 (0.43) IRAK4JAK3ROCK2ROCK1BTK
SCHEMBL4780230 0.76 CHEK1 (0.56) IRAK4TRPA1JAK3AURKACYP2C19
SCHEMBL9928271 0.73 LRRK2 (0.36) IRAK4JAK3STK3KDM4ELRRK2
SCHEMBL9928275 0.71 EGFR (0.58) CDK1BRAFTNNI3K
SCHEMBL21106699 0.71 IRAK4 (1.00) IRAK4BTK
SCHEMBL16371979 0.70 IRAK4 (0.43) IRAK4TRPA1JAK3CDK2LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120149902-A1 PYRROLO[2,3-D]PYRIMIDINE DERIVATIVE UBE INDUSTRIES, LTD. (JP) 2012-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149902-A1 PYRROLO[2,3-D]PYRIMIDINE DERIVATIVE ERBB2, EGFR, FGFR1 IRAK4 1112/4885TRPA1 827/4885JAK3 204/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.